Alam Kamran 4
4 · Taysha Gene Therapies, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Alam Kamran
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2025-01-02+431,000→ 1,271,937 total - Award
Employee Stock Option (right to buy)
2025-01-02+431,000→ 431,000 totalExercise: $1.85Exp: 2035-01-02→ Common Stock (431,000 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") award. The RSU grant was approved by the Issuer's compensation committee of the board of directors and will be effective as of the date the Issuer has an effective Registration Statement on Form S-8 registering the shares available for issuance under the 2020 Stock Incentive Plan. The RSUs will vest in four equal annual installments beginning on January 2, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.
- [F2]25% of the total number of shares underlying the option shall vest and become exercisable on January 2, 2026 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.